Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
49.10
+0.16 (0.32%)
At close: Jan 29, 2026, 4:00 PM EST
49.06
-0.03 (-0.07%)
After-hours: Jan 29, 2026, 4:20 PM EST
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 674 employees as of December 31, 2024. The number of employees increased by 22 or 3.37% compared to the previous year.
Employees
674
Change (1Y)
22
Growth (1Y)
3.37%
Revenue / Employee
$1,011,185
Profits / Employee
-$28,364
Market Cap
2.81B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 674 | 22 | 3.37% |
| Dec 31, 2023 | 652 | 40 | 6.54% |
| Dec 31, 2022 | 612 | 37 | 6.43% |
| Jun 30, 2022 | 603 | - | - |
| Dec 31, 2021 | 575 | 12 | 2.13% |
| Dec 31, 2020 | 563 | 99 | 21.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,700 |
| Perrigo Company | 8,379 |
| Amneal Pharmaceuticals | 8,300 |
| HUTCHMED (China) | 1,780 |
| Alvotech | 1,012 |
| ANI Pharmaceuticals | 897 |
| Lantheus Holdings | 808 |
| Prestige Consumer Healthcare | 600 |
SUPN News
- 14 days ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 7 weeks ago - Supernus Pharmaceuticals, Inc. (SUPN) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference - GlobeNewsWire
- 2 months ago - Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 3 months ago - Supernus Pharmaceuticals, Inc. (SUPN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Supernus Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 - GlobeNewsWire